| Literature DB >> 33128820 |
Fatemeh Saberi Hosnijeh1,2, Delphine Casabonne3,4, Alexandra Nieters5, Marta Solans4,6, Sabine Naudin7, Pietro Ferrari7, James D Mckay8, Yolanda Benavente3,4, Elisabete Weiderpass9, Heinz Freisling7, Gianluca Severi10,11,12, Marie-Christine Boutron Ruault10,11, Caroline Besson10,13,14, Claudia Agnoli15, Giovanna Masala16, Carlotta Sacerdote17, Rosario Tumino18, José María Huerta19,20, Pilar Amiano21, Miguel Rodriguez-Barranco22,23,24, Catalina Bonet25, Aurelio Barricarte4,26,27, Sofia Christakoudi28,29, Anika Knuppel30, Bas Bueno-de-Mesquita31,32, Matthias B Schulze33,34, Rudolf Kaaks35, Federico Canzian36, Florentin Späth37, Mats Jerkeman38,39, Charlotta Rylander40, Anne Tjønneland40,41, Anja Olsen41, Kristin Benjaminsen Borch42, Roel Vermeulen1,43,44.
Abstract
To better understand the role of individual and lifestyle factors in human disease, an exposome-wide association study was performed to investigate within a single-study anthropometry measures and lifestyle factors previously associated with B-cell lymphoma (BCL). Within the European Prospective Investigation into Cancer and nutrition study, 2402 incident BCL cases were diagnosed from 475 426 participants that were followed-up on average 14 years. Standard and penalized Cox regression models as well as principal component analysis (PCA) were used to evaluate 84 exposures in relation to BCL risk. Standard and penalized Cox regression models showed a positive association between anthropometric measures and BCL and multiple myeloma/plasma cell neoplasm (MM). The penalized Cox models additionally showed the association between several exposures from categories of physical activity, smoking status, medical history, socioeconomic position, diet and BCL and/or the subtypes. PCAs confirmed the individual associations but also showed additional observations. The PC5 including anthropometry, was positively associated with BCL, diffuse large B-cell lymphoma (DLBCL) and MM. There was a significant positive association between consumption of sugar and confectionary (PC11) and follicular lymphoma risk, and an inverse association between fish and shellfish and Vitamin D (PC15) and DLBCL risk. The PC1 including features of the Mediterranean diet and diet with lower inflammatory score showed an inverse association with BCL risk, while the PC7, including dairy, was positively associated with BCL and DLBCL risk. Physical activity (PC10) was positively associated with DLBCL risk among women. This study provided informative insights on the etiology of BCL.Entities:
Keywords: exposome; exposome-wide association study; lifestyle; lymphoma; prospective study
Mesh:
Year: 2020 PMID: 33128820 PMCID: PMC8048490 DOI: 10.1002/ijc.33369
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.316
General characteristics of study population
| Whole cohort | BCL | |
|---|---|---|
| Size, n | 475 426 | 2402 |
| Age, mean (SD) | 51.2 (9.94) | 55.7 (8.10) |
| Female (%) | 70.2 | 57.4 |
| BMI, mean (SD) | 25.4 (4.27) | 25.97 (4.24) |
| Education (%) | ||
| None/primary school | 30.3 | 35.1 |
| Technical/professional school | 23.8 | 27.5 |
| Secondary school | 21.0 | 15.7 |
| Longer education (incl. university degree) | 24.9 | 21.7 |
| Country (%) | ||
| France | 14.2 | 8.5 |
| Italy | 9.4 | 9.1 |
| Spain | 8.4 | 8.1 |
| United Kingdom | 15.8 | 17.7 |
| The Netherlands | 7.7 | 7.2 |
| Greece | 5.5 | 1.6 |
| Germany | 10.2 | 7.1 |
| Sweden | 10.2 | 14.3 |
| Denmark | 11.5 | 21.1 |
| Norway | 7.1 | 5.4 |
| B‐cell lymphoma subtypes (%) | ||
| DLBCL | 20.3 | |
| CLL | 22.4 | |
| FL | 15.9 | |
| MM | 28.1 | |
| Others | 13.3 |
Abbreviations: BMI, body mass index; CLL, chronic lymphocytic leukemia/small lymphocytic leukemia; DLBCL, diffuse large B‐cell lymphoma; FL, follicular lymphoma; MM, plasma cell neoplasm/multiple myeloma.
FIGURE 1Standard Cox regression for individual exposure adjusted for country, age and sex in total BCL and subtypes. Vertical axis shows the −Log10 p FDR value and blue line shows pFDR = 0.05. See Table S2 for name, type and unit of the exposures. BCL, B‐cell lymphoma; FDR, false discovery rate [Color figure can be viewed at wileyonlinelibrary.com]
Regression coefficient of the selected exposures by LASSO model for total BCL and major subtypes
| BCL | CLL | FL | DLBCL | MM | ||
|---|---|---|---|---|---|---|
| Exposure | PC | Estimate | Estimate | Estimate | Estimate | Estimate |
| Height | 16 | 0.008 | ||||
| Weight | 5 | 0.001 | 0.005 | 0.004 | ||
| Hip circumference | 5 | 0.004 | 0.001 | |||
| Fruit, nuts, and seeds | 1 | −0.000002 | ||||
| Dairy products | 7 | 0.0001 | 0.0002 | |||
| Sugar and confectionary | 11 | 0.00002 | 0.001 | |||
| Condiments and sauces | 17 | −0.001 | −0.0001 | |||
| Total polyunsaturated fatty acids | 6 | −0.002 | ||||
| Total fats, animal origin | 2 | 0.002 | ||||
| Vitamin D | 15 | −0.016 | ||||
| Retinol | 19 | −0.00002 | ||||
| Current smoker | 3 | −0.044 | ||||
| Currently smoking >25/day | 18 | 0.330 | ||||
| Currently smoking cigars | 19 | −0.030 | ||||
| Total physical activity index (sex‐specific) (Active) | 10 | 0.022 | 0.141 | |||
| Manual work | 10 | 0.082 | 0.122 | |||
| Recreational activity (METS) | 8 | 0.0003 | ||||
| Standing occupation | 20 | −0.040 | ||||
| Hypertension | 14 | −0.042 | ||||
| Myocardial infarction | 21 | 0.182 | ||||
| Stroke | 21 | −0.010 | ||||
| Education | 16 | −0.010 |
Note: Country, age and gender were forced into the penalized Cox models. All variables were standardized. Penalty parameter, lambda, was derived using 5‐fold cross‐validation. Regression coefficients were obtained at lambda minimum (the value of λ at the lowest cross‐validation error). Positive coefficients indicate that an exposure is associated with higher risk of lymphoma, and vice versa for negative coefficients. See Table S2 for name, type and unit of the exposures.
Abbreviations: BCL, B‐cell lymphoma; CLL, chronic lymphocytic leukemia/small lymphocytic leukemia; DLBCL, diffuse large B‐cell lymphoma; FL, follicular lymphoma; METS, Metabolic Equivalent of Task/week; MM, plasma cell neoplasm/multiple myeloma; PC, principal component.
FIGURE 2A heatmap for the correlation of each exposure with each principal component. The color of the intersection of an exposure (vertical axis) and a principal component (horizontal axis) indicates the dimension of the correlation: dark blue indicates a highly negative correlation; dark red indicates a highly positive correlation; The staircase‐like high correlation line in the figure indicates that all exposures are correlated with one of the principal components without much overlap. See Table S2 for name, type and unit of the exposures [Color figure can be viewed at wileyonlinelibrary.com]
Multivariable HRs and 95% CIs of the PCs for total BCL and major subtypes mutually adjusted for other PCs
| BCL | CLL | FL | DLBCL | MM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PC | HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) |
|
| 1 | 0.94 (0.89‐0.99) | .03 | 0.94 (0.84‐1.05) | .26 | 0.96 (0.84‐1.10) | .58 | 0.97 (0.87‐1.10) | .66 | 0.91 (0.82‐1.01) | .08 |
| 2 | 1.03 (0.98‐1.08) | .27 | 1.10 (0.99‐1.21) | .07 | 0.97 (0.85‐1.10) | .63 | 0.98 (0.88‐1.10) | .79 | 1.01 (0.92‐1.10) | .91 |
| 3 | 0.99 (0.95‐1.03) | .65 | 0.99 (0.90‐1.08) | .75 | 0.94 (0.85‐1.05) | .31 | 1.01 (0.92‐1.11) | .78 | 0.99 (0.91‐1.07) | .82 |
| 4 | 1.03 (0.99‐1.08) | .17 | 1.00 (0.91‐1.11) | .95 | 1.02 (0.91‐1.15) | .73 | 0.99 (0.90‐1.11) | .94 | 1.06 (0.98‐1.16) | .16 |
| 5 | 1.09 (1.04‐1.15) | .0001 | 1.06 (0.96‐1.18) | .25 | 1.02 (0.89‐1.16) | .78 | 1.15 (1.03‐1.28) | .01 | 1.18 (1.07‐1.29) | .0001 |
| 6 | 1.00 (0.95‐1.05) | .97 | 0.91 (0.81‐1.02) | .10 | 0.94 (0.82‐1.08) | .42 | 0.96 (0.85‐1.08) | .48 | 1.06 (0.96‐1.16) | .25 |
| 7 | 1.04 (1.00‐1.09) | .04 | 1.01 (0.92–1.10) | .89 | 1.09 (0.98‐1.20) | .11 | 1.12 (1.03‐1.22) | .01 | 1.02 (0.94‐1.10) | .62 |
| 8 | 1.00 (0.96‐1.05) | .90 | 0.98 (0.89‐1.07) | .61 | 0.95 (0.85‐1.06) | .39 | 1.05 (0.95‐1.15) | .33 | 1.00 (0.92‐1.08) | .95 |
| 9 | 1.03 (0.99‐1.07) | .20 | 1.04 (0.96‐1.14) | .31 | 1.08 (0.97‐1.20) | .15 | 1.02 (0.93‐1.12) | .67 | 0.98 (0.90‐1.06) | .62 |
| 10 | 1.06 (1.02‐1.11) | .01 | 1.07 (0.98‐1.17) | .14 | 1.10 (0.98‐1.22) | .10 | 1.12 (1.02‐1.22) | .02 | 1.07 (0.98–1.16) | .13 |
| 11 | 1.04 (0.99–1.08) | .07 | 0.98 (0.90‐1.08) | .74 | 1.13 (1.03‐1.25) | .01 | 1.06 (0.97‐1.16) | .18 | 1.02 (0.94–1.10) | .67 |
| 12 | 1.05 (0.99‐1.13) | .13 | 1.06 (0.92‐1.22) | .43 | 1.02 (0.86‐1.21) | .82 | 1.09 (0.94‐1.26) | .25 | 1.09 (0.95‐1.23) | .21 |
| 13 | 1.04 (0.98‐1.10) | .19 | 1.01 (0.89‐1.15) | .86 | 1.02 (0.87‐1.18) | .82 | 1.12 (0.98‐1.27) | .08 | 1.07 (0.96‐1.19) | .21 |
| 14 | 0.98 (0.94‐1.02) | .24 | 0.98 (0.90‐1.07) | .64 | 0.92 (0.82‐1.03) | .16 | 0.99 (0.90‐1.09) | .81 | 1.03 (0.95‐1.11) | .50 |
| 15 | 0.99 (0.95–1.05) | .86 | 1.04 (0.94‐1.16) | .45 | 1.06 (0.94‐1.20) | .35 | 0.86 (0.76‐0.98) | .02 | 1.05 (0.96–1.16) | .27 |
| 16 | 1.02 (0.97‐1.08) | .37 | 1.05 (0.94‐1.17) | .37 | 1.08 (0.94‐1.23) | .28 | 1.01 (0.90‐1.14) | .81 | 0.97 (0.88‐1.07) | .59 |
| 17 | 0.95 (0.90‐1.00) | .06 | 0.91 (0.81‐1.03) | .12 | 0.95 (0.82‐1.09) | .47 | 1.02 (0.91–1.15) | .69 | 0.91 (0.82‐1.02) | .10 |
| 18 | 0.99 (0.95‐1.04) | .83 | 1.01 (0.92–1.11) | .83 | 1.00 (0.89‐1.13) | .96 | 1.05 (0.96‐1.15) | .28 | 0.95 (0.86‐1.04) | .25 |
| 19 | 1.00 (0.96–1.05) | .99 | 0.96 (0.88‐1.06) | .46 | 1.03 (0.92‐1.16) | .56 | 1.02 (0.92‐1.12) | .76 | 1.00 (0.92‐1.09) | .97 |
| 20 | 0.98 (0.94–1.02) | .37 | 0.94 (0.85‐1.03) | .17 | 0.97 (0.87‐1.08) | .61 | 0.92 (0.83‐1.02) | .11 | 1.03 (0.95‐1.13) | .43 |
| 21 | 1.01 (0.97‐1.05) | .53 | 1.03 (0.95–1.11) | .47 | 0.91 (0.80‐1.03) | .15 | 1.05 (0.97‐1.14) | .24 | 1.02 (0.95‐1.10) | .57 |
| 22 | 0.98 (0.94‐1.02) | .29 | 1.03 (0.96‐1.11) | .40 | 0.94 (0.84‐1.04) | .23 | 0.95 (0.87‐1.03) | .22 | 0.99 (0.92‐1.06) | .76 |
Note: Model included age, gender, country and all PCs; Figure 2 and Table S8 shows name and loading of individual variables in PCs.
Abbreviations: BCL, B‐cell lymphoma; CIs, confidence intervals; CLL, chronic lymphocytic leukemia/small lymphocytic leukemia; DLBCL, diffuse large B‐cell lymphoma; FL, follicular lymphoma; HR, hazard ratios; MM, plasma cell neoplasm/multiple myeloma; PC, principal component.
Multivariate Cox regression of the principal components for total BCL and major subtypes mutually adjusted for other PCs stratified by sex
| HR (95% CI) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PC | BCL | CLL | FL | DLBCL | MM | |||||
| Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | |
| 1 | 0.94 (0.87–1.03) | 0.94 (0.88‐1.01) | 0.99 (0.84‐1.17) | 0.91 (0.78‐1.07) | 0.98 (0.77‐1.24) | 0.95 (0.81‐1.12) | 1.01 (0.84‐1.21) | 0.92 (0.79‐1.07) |
| 0.98 (0.86‐1.12) |
| 2 | 1.03 (0.96‐1.10) | 1.03 (0.96‐1.11) | 1.11 (0.97‐1.27) | 1.09 (0.93‐1.28) | 0.84 (0.68‐1.04) | 1.06 (0.90‐1.25) | 1.03 (0.89‐1.21) | 0.92 (0.79‐1.08) | 1.04 (0.92‐1.18) | 0.95 (0.83‐1.10) |
| 3 | 1.03 (0.97‐1.10) | 0.95 (0.90‐1.01) | 1.06 (0.93‐1.20) | 0.91 (0.79‐1.04) | 0.99 (0.82‐1.19) | 0.93 (0.81‐1.07) | 1.10 (0.95‐1.27) | 0.93 (0.82‐1.06) | 1.05 (0.94‐1.18) | 0.92 (0.81‐1.03) |
| 4 | 1.03 (0.96–1.10) | 1.02 (0.96‐1.09) | 0.97 (0.84‐1.11) | 1.03 (0.89‐1.19) | 1.07 (0.89‐1.29) | 0.96 (0.82‐1.12) | 1.00 (0.85‐1.17) | 1.00 (0.87‐1.15) | 1.04 (0.92‐1.18) | 1.07 (0.94‐1.20) |
| 5 |
|
| 1.07 (0.91‐1.25) | 1.07 (0.92‐1.23) | 0.97 (0.77‐1.23) | 1.06 (0.91‐1.24) | 0.97 (0.81‐1.17) |
|
| 1.09 (0.97‐1.23) |
| 6 | 1.02 (0.95‐1.09) | 0.97 (0.90‐1.05) | 0.93 (0.80‐1.08) | 0.87 (0.73‐1.04) | 1.02 (0.84‐1.26) | 0.90 (0.75‐1.08) | 1.00 (0.85‐1.19) | 0.91 (0.77‐1.08) | 1.03 (0.90‐1.17) | 1.08 (0.94‐1.24) |
| 7 | 1.02 (0.96‐1.09) |
| 1.02 (0.91‐1.15) | 0.99 (0.87‐1.13) | 1.12 (0.96‐1.32) | 1.05 (0.92‐1.20) | 1.00 (0.88‐1.15) |
| 0.99 (0.88‐1.11) | 1.05 (0.94‐1.18) |
| 8 | 1.02 (0.95–1.09) | 1.00 (0.94‐1.05) | 0.97 (0.85‐1.12) | 0.97 (0.86‐1.10) | 1.07 (0.87‐1.31) | 0.91 (0.80‐1.04) | 1.14 (0.97‐1.33) | 1.00 (0.89‐1.13) | 0.94 (0.82‐1.07) | 1.06 (0.95‐1.17) |
| 9 | 1.01 (0.96‐1.07) | 1.05 (0.96‐1.14) | 1.03 (0.93‐1.14) | 1.10 (0.92‐1.32) | 0.98 (0.84‐1.14) |
| 1.01 (0.90‐1.13) | 1.00 (0.82‐1.21) | 0.99 (0.90‐1.09) | 0.92 (0.77‐1.11) |
| 10 | 1.06 (1.00‐1.13) | 1.06 (1.00‐1.13) | 1.10 (0.97‐1.25) | 1.04 (0.90‐1.19) | 1.03 (0.86‐1.23) | 1.14 (0.99‐1.31) | 1.03 (0.89‐1.19) |
| 1.10 (0.98‐1.24) | 1.01 (0.90‐1.15) |
| 11 | 1.02 (0.96‐1.07) |
| 0.98 (0.87–1.10) | 0.98 (0.84‐1.14) | 1.06 (0.90‐1.25) |
| 0.98 (0.88‐1.11) |
| 1.05 (0.95‐1.16) | 0.94 (0.83‐1.07) |
| 12 | 1.06 (0.96‐1.18) | 1.05 (0.95‐1.15) | 1.09 (0.89‐1.33) | 1.02 (0.83‐1.25) | 0.91 (0.67‐1.25) | 1.08 (0.87‐1.34) | 0.93 (0.74‐1.18) |
| 1.20 (0.99‐1.44) | 0.97 (0.81‐1.16) |
| 13 | 0.98 (0.91‐1.07) |
| 1.02 (0.87‐1.21) | 0.99 (0.92–1.20) | 0.80 (0.62‐1.04) |
| 0.89 (0.73‐1.08) |
| 1.15 (1.00‐1.33) | 0.98 (0.83‐1.16) |
| 14 | 0.97 (0.91‐1.04) | 0.97 (0.92‐1.03) | 0.95 (0.83‐1.08) | 1.01 (0.89‐1.14) | 0.91 (0.75‐1.10) | 0.93 (0.81‐1.07) | 0.96 (0.83‐1.11) | 1.01 (0.90‐1.14) | 1.03 (0.92‐1.15) | 1.02 (0.92‐1.13) |
| 15 | 0.99 (0.91‐1.07) | 1.00 (0.94‐1.08) | 1.01 (0.87‐1.18) | 1.07 (0.93‐1.24) | 1.11 (0.89‐1.38) | 1.04 (0.90‐1.21) |
| 0.96 (0.82‐1.13) | 1.14 (1.00‐1.29) | 1.00 (0.87‐1.15) |
| 16 | 0.98 (0.90‐1.06) | 1.06 (0.99‐1.15) | 1.00 (0.86‐1.17) | 1.13 (0.96‐1.33) | 1.08 (0.86‐1.35) | 1.01 (0.85‐1.20) | 0.91 (0.77‐1.09) | 1.13 (0.96‐1.32) | 0.97 (0.84‐1.12) | 0.99 (0.85‐1.14) |
| 17 |
| 1.02 (0.94‐1.11) | 0.85 (0.72‐1.01) | 0.99 (0.82‐1.18) | 0.95 (0.76‐1.18) | 0.95 (0.79‐1.14) | 0.85 (0.71‐1.02) | 1.16 (0.99‐1.37) | 0.85 (0.73‐1.00) | 1.00 (0.86‐1.16) |
| 18 | 1.02 (0.96‐1.08) | 0.95 (0.88‐1.03) | 1.03 (0.93‐1.15) | 0.96 (0.80‐1.15) | 1.00 (0.85‐1.18) | 1.01 (0.85‐1.20) | 1.10 (0.98‐1.22) | 0.98 (0.83‐1.15) | 0.98 (0.88‐1.09) | 0.83 (0.68‐1.02) |
| 19 | 0.97 (0.91‐1.04) | 1.02 (0.96‐1.09) | 0.95 (0.84‐1.08) | 0.96 (0.83‐1.12) | 1.08 (0.96‐1.20) | 0.97 (0.83‐1.15) | 0.93 (0.81‐1.08) | 1.13 (0.98‐1.30) | 1.01 (0.90‐1.14) | 0.96 (0.84‐1.10) |
| 20 | 1.03 (0.96‐1.10) |
| 0.98 (0.85‐1.12) | 0.89 (0.78‐1.02) | 0.92 (0.76‐1.11) | 1.00 (0.87‐1.14) | 1.10 (0.95‐1.27) |
| 1.01 (0.89‐1.14) | 1.07 (0.94‐1.19) |
| 21 | 1.01 (0.95‐1.06) | 1.02 (0.96‐1.08) | 1.02 (0.92‐1.13) | 1.02 (0.90‐1.16) |
| 1.02 (0.88‐1.17) | 1.05 (0.94‐1.17) | 1.05 (0.93‐1.19) | 1.02 (0.92‐1.12) | 1.02 (0.92‐1.14) |
| 22 | 0.97 (0.93‐1.02) | 0.99 (0.93‐1.06) | 0.98 (0.89‐1.08) | 1.12 (1.00‐1.26) | 0.91 (0.77‐1.06) | 0.98 (0.84‐1.13) | 0.98 (0.88‐1.09) | 0.90 (0.77‐1.05) | 1.01 (0.93‐1.10) | 0.90 (0.77‐1.06) |
Note: Model included age, country and all PCs. Bold values are significant at P < .05.
Abbreviations: BCL, B‐cell lymphoma; CI, confidence interval; CLL, chronic lymphocytic leukemia/small lymphocytic leukemia; DLBCL, diffuse large B‐cell lymphoma; FL, follicular lymphoma; HR, hazard ratios; MM, plasma cell neoplasm/multiple myeloma; PC, principal component.